Edge AI Tech Challenge
IMpatient Innovation awards 2025
On the opening night of SNX 2025, the Impatient Innovation Awards will honor the Israeli mindset of doing first, adapting fast, and finding opportunity in constraint. This is your chance to shine the spotlight on an innovator who moves with purpose and turns challenges into action.
About the Challange
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
What You Have A Chance To Win?
On-Stage Spotlight
During SNX 2025 opening ceremony and awards
(November 3, 2025)
Media Exposure
Through SNX 2025 conference and
Startup Nation Central channels
Access Network
Global partners, investors, and
business leaders attending SNX 2025
Who Is This Challenge For?
This challenge is intentionally sector-agnostic. You do not need to be an “AI infrastructure company” or a semiconductor startup to apply. If your solution benefits from fast, local intelligence, edge AI is already relevant. Individuals and teams can apply, even if they are not registered companies. But all applicants must submit at least a mockup or proof of concept, and participants must be based in Israel.
We encourage applications from the following sectors:
- Health, medical devices, and digital health
- Mobility, robotics, drones, and autonomy
- Industrial tech, manufacturing, and IoT
- Climate, energy, agriculture, and water
- Retail, logistics, and smart infrastructure
- Consumer devices, wearables, and smart assistants
- Security, safety, and situational awareness
- Reducing the Treatment Burden for Patients and Caregivers
- Remote monitoring technologies, including solutions for remote blood testing (e.g., chemistry panels) and adverse event tracking.
- Technologies or services that improve patient experience and accessibility while minimizing daily disruptions.
- Enhancing Patient Quality of Life
- Novel approaches for managing CLL-related fatigue and pain.
- Digital health tools, wearables, or therapeutics that support symptom relief and overall well-being.
- Patient-centric innovations that empower individuals to lead active and fulfilling lives
AbbVie Israel welcomes any additional solutions that improve quality of care or quality of life for CLL patients and their caregivers.
TRL 5
Solutions should have a Technology Readiness Level (TRL) of 5 and above.
Focus Area
Preference will be given to solutions addressing the areas of focus.
Multi-Use
Good solutions will address at least one focus area, while great solutions will tackle multiple areas, including technologies.
EMR-Ready
Priority will be given to solutions that integrate with Electronic Medical Records (EMR) based on FHIR.
Nominate an Innovator
Celebrating Bold, Determined Disruptors
Honoring the problem-solvers who move first, act fast, tackle urgent challenges, and deliver lasting impact
Timeline
Febuary 1
Nominations Open
October 15
Nominations Close
October 22
Finalists Announced
November 3
SNX Opening Ceremony
November 4
SNX 2025
Advisory Committee
Dr. Yael Gruenbaum-Cohen
Partner
aMoon Fund
Dr. Avi Matan
General Manager
AbbVie Israel
Prof. Tamar Tadmor
Clinical Associate Professor Head of Hematology unit Bnai-Zion Medical Center
Giora Sharf
CEO
Flute of Light and CML Patients Organizations
Dr. David Tamoschus
Commercial Director, Venclyxto CLL, Oncology, Europe
AbbVie
Prof. Yair Herishanu
Hematology Specialist, Director of the CLL Unit and the Hematology Clinic
Ichilov Medical Center
Liat Alon
CEX Director
AbbVie Israel
Dr. Moran Barak
Medical Director
AbbVie Israel
Dr. Iris Adler
Head of BD & Global Partnerships
8400 Health Network
Nataly Hason
Oncology Commercial Director
AbbVie Israel
Startup Nation Central is a free-acting NGO providing global solution seekers frictionless access to Israel’s bold and impatient innovators to help tackle the world’s most pressing challenges.